Questions discussed in this category
Are there any potency or effectiveness preferences that lead to that decision?
Considering the recent article in CHEST that describes the increasing incidence of fungal pneumonia Azar. Chest 2024
Do you prescribe it universally or based on specific risk factors?
Are there situations in which you would continue the possible offending agent with close monitoring?
2744419860256082567526624265792491523133249112370522838
Papers discussed in this category
Frontiers in psychiatry, 2018 Oct 08
Pharmacoepidemiology and drug safety, 2018 Sep 25
The Journal of clinical psychiatry, 2020 Aug 04
International journal of molecular sciences, 2022 Mar 13
Hepatology (Baltimore, Md.), 2012 Apr
Drug and alcohol dependence, 2024 Sep 07
JAMA psychiatry, 2025 Apr 01
Am J Respir Crit Care Med, 2019 Sep 1
Chest, 2023 Oct 07
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024 Mar 05
Physiological reports, 2019-05